News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

iCAD, Inc. (ICAD) Announces More Than 1,000 Early Stage Breast Cancer Patients Treated With Intraoperative Radiation Therapy (IORT) Using The Xoft System


3/6/2014 9:47:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHUA, N.H. & MIAMI--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced image analysis and radiation therapy solutions for the early identification and treatment of cancer, today announced at the 31st Annual Miami Breast Cancer Conference that more than 1,000 early stage breast cancer patients have been treated with Intraoperative Radiation Therapy (IORT) using the Xoft® Axxent® Electronic Brachytherapy System®. With IORT, a full course of radiation therapy is delivered to the patient in the operating room immediately following lumpectomy, replacing six to eight weeks of daily traditional radiation.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES